Your browser doesn't support javascript.
loading
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.
Huang, Franklin W; Mosquera, Juan Miguel; Garofalo, Andrea; Oh, Coyin; Baco, Maria; Amin-Mansour, Ali; Rabasha, Bokang; Bahl, Samira; Mullane, Stephanie A; Robinson, Brian D; Aldubayan, Saud; Khani, Francesca; Karir, Beerinder; Kim, Eejung; Chimene-Weiss, Jeremy; Hofree, Matan; Romanel, Alessandro; Osborne, Joseph R; Kim, Jong Wook; Azabdaftari, Gissou; Woloszynska-Read, Anna; Sfanos, Karen; De Marzo, Angelo M; Demichelis, Francesca; Gabriel, Stacey; Van Allen, Eliezer M; Mesirov, Jill; Tamayo, Pablo; Rubin, Mark A; Powell, Isaac J; Garraway, Levi A.
Afiliação
  • Huang FW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. levi_garraway@dfci.harvard.edu franklin_huang@dfci.harvard.edu ipowell@med.wayne.edu rubinma@med.cornell.edu.
  • Mosquera JM; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Garofalo A; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Oh C; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.
  • Baco M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Amin-Mansour A; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Rabasha B; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Bahl S; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Mullane SA; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Robinson BD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Aldubayan S; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Khani F; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Karir B; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Kim E; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.
  • Chimene-Weiss J; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Hofree M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Romanel A; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Osborne JR; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Kim JW; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine-New York Presbyterian, New York, New York.
  • Azabdaftari G; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York.
  • Woloszynska-Read A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sfanos K; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • De Marzo AM; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Demichelis F; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Gabriel S; Centre for Integrative Biology, University of Trento, Trento, Italy.
  • Van Allen EM; Centre for Integrative Biology, University of Trento, Trento, Italy.
  • Mesirov J; Department of Radiology, Weill Cornell Medicine, New York, New York.
  • Tamayo P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Rubin MA; Cancer Program, the Broad Institute of Harvard and MIT, Cambridge, Massachusetts.
  • Powell IJ; Department of Pathology, Roswell Park Cancer Institute, Roswell Park, New York.
  • Garraway LA; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Roswell Park, New York.
Cancer Discov ; 7(9): 973-983, 2017 09.
Article em En | MEDLINE | ID: mdl-28515055

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Repressoras Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Proteínas Repressoras Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Cancer Discov Ano de publicação: 2017 Tipo de documento: Article